HPV testing for primary cervical cancer screening -- project protocol

The objective of this HTA is to address the policy question by assessing the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patient experience and perspectives, ethical issues, implementation issues, and environmental impact of HPV testing as a primary screening tool for cer...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa CADTH 2017, May 2017
Series:CADTH optimal use report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The objective of this HTA is to address the policy question by assessing the diagnostic test accuracy, clinical utility, safety, cost-effectiveness, patient experience and perspectives, ethical issues, implementation issues, and environmental impact of HPV testing as a primary screening tool for cervical cancer screening
Item Description:"PROSPERO Registration Number: CDR42017058463."
Physical Description:1 PDF file (78 pages) illustrations